Ozempic: The Miracle Drug for Shedding Pounds
Here are a few reasons why you should read this article:
Understand the high cost of prescription drugs: The
article sheds light on the high cost of prescription drugs and how it affects
people who can't afford them. It also discusses the impact of drug pricing on
the healthcare industry as a whole.
Hey, have you seen Amy Schumer, Elon Musk, or Chelsea
Handler lately? They're looking like they've lost some weight, right? Well,
they've got a secret weapon: Ozempic. This little drug is meant to treat
diabetes, but it's got a pretty sweet side effect of making you drop weight
like crazy. Unfortunately, it's only available to those with deep pockets. So
if you're not a millionaire, you're out of luck.
Are you tired of being overweight? Want to try
Ozempic, the drug that can help you lose up to 25% of your body weight? Well,
good luck with that. This drug is only for the high rollers. If you're just a
regular Joe, you'll have to wait until the patent expires in 2032. By then, you
might be skinny, but you'll also be broke.
Novo Nordisk is the Danish company that created
Ozempic. They've got a patent on semaglutide, the active ingredient in Ozempic
and Wegovy. This means they can charge whatever they want for the drug. The
Institute for Clinical and Economic Review estimates that the drugs should be
44% to 57% cheaper than what they're currently sold for.
Thanks to Ozempic's success, other drug companies are
scrambling to create their own weight-loss injections and pills. These "me
too" drugs are different molecules that have the same effect on the body
as Ozempic. They're cheaper to make because they don't have to carry the burden
of being the original innovator in the market. So if you can't afford Ozempic,
don't worry. There will be plenty of knock-offs on the market soon.
Antidiabetic drugs like Ozempic and Mounjaro are not
covered for obesity by federal and most employee-sponsored health insurances.
So even if you're lucky enough to have insurance, you're still out of luck if
you want to use it for weight loss purposes. And if you don't have insurance?
Well, good luck affording the $1,000/month price tag for Wegovy (which is just a
different dosage of Ozempic).
Novo Nordisk has a patent on semaglutide until 2032,
which means they can charge whatever they want for Ozempic and Wegovy. The
Institute for Clinical and Economic Review estimates that the drugs should be
44% to 57% cheaper than what they're currently sold for. But since creating
semaglutide cost them hundreds of millions of dollars in clinical trials, they
need to make a lot of money back before their competitors catch up.
There are plenty of "me too" drugs in the
works that will have the same effect on your body as Ozempic and Wegovy. But
even when those competitors enter the market, it still isn’t likely that
low-income people who are most heavily affected by obesity will be able to
access the drugs for several years. And if you're hoping insurance will cover
these new drugs, think again - most insurances only cover weight-loss drugs for
treating diabetes, not obesity.arge a lot! The Institute for Clinical and
Economic Review estimates that the drugs should be 44% to 57% cheaper than what
they're currently sold for. But hey, who cares about fair pricing when you're
raking in billions? Novo Nordisk has a short time to recoup as much profit or
money as they can before their monopoly expires, so they're going to charge as
much as they can. And since creating semaglutide cost them hundreds of millions
of dollars in clinical trials, they need to make a lot of money back before
their competitors catch up.
Don't worry if you can't afford Ozempic or Wegovy -
there are plenty of "me too" drugs in the works that will have the
same effect on your body. These new drugs are much cheaper to create because
competitor companies don’t carry the burden of being the innovator in the
market. But even when those competitors enter the market, it still isn’t likely
that low-income people who are most heavily affected by obesity will be able to
access the drugs for several years. And if you're hoping insurance will cover
these new drugs, think again - most insurances only cover weight-loss drugs for
treating diabetes, not obesity. Looks like being skinny is still a luxury
reserved for the wealthy!
0 Comments